State Street SPDR S&P Biotech ETF (XBI) Dividend Yield, History & Forecast

State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.35% ($0.54 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 24, 2026. market capitalization is approximately $8.16B. Review XBI dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

XBI fund composition

XBI holds 165 positions, with 18.0% of assets in its ten largest. It charges an expense ratio of 0.35%, and manages $10.51B.

Top 10 holdings

HoldingWeight
MRNAMODERNA INC2.36%
TWSTTWIST BIOSCIENCE CORP1.98%
NTRANATERA INC1.89%
HALOHALOZYME THERAPEUTICS INC1.75%
BIIBBIOGEN INC1.70%
AMGNAMGEN INC1.69%
UTHRUNITED THERAPEUTICS CORP1.68%
ABBVABBVIE INC1.66%
SYRESPYRE THERAPEUTICS INC1.63%
GILDGILEAD SCIENCES INC1.63%

Sector allocation

Healthcare99.3%Financial Services0.7%Cash & Others0.2%

Compare XBI

Yield, fees, returns and holdings overlap, side by side.

Frequently Asked Questions about State Street SPDR S&P Biotech ETF (XBI)

What is State Street SPDR S&P Biotech ETF's dividend yield?
State Street SPDR S&P Biotech ETF (XBI) pays a current trailing twelve-month dividend yield of 0.35%, which works out to $0.54 per share annually based on the most recent payout schedule.
When does State Street SPDR S&P Biotech ETF pay distributions?
The most recent ex-dividend date was June 22, 2026. The next scheduled dividend payment date is June 24, 2026.
How many years has State Street SPDR S&P Biotech ETF increased its dividend?
State Street SPDR S&P Biotech ETF (XBI) has increased its dividend for 2 consecutive years.
What does State Street SPDR S&P Biotech ETF invest in?
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series...